PRWeb The Leader Press Release Distribution

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for June 18, 2008 Subscribe to this News Feed    
 

Dermapril-SP Earns Perfect Scores in Rigorous Dermatologic Safety Testing

Rauscher | Bekke's Age-Defying Wrinkle Cream Clinically Proven to be 'Hypoallergenic' and 'Safe for Sensitive Skin.'

Sometimes people with sensitive skin are nervous about trying a new skin care product because they fear allergic reactions

Miami Beach, FL (PRWEB) June 18, 2008 -- Demapril-SP, the age-defying wrinkle cream from Rauscher | Bekke, passed rigorous testing conducted by a trusted research laboratory and can now be labeled 'hypoallergenic' and 'safe for sensitive skin,' the company announced today.

Dermapril-SP by Rauscher | Bekke
Dermapril-SP by Rauscher | Bekke

New York-based Cantor Research Laboratories, Inc. conducted two separate standardized tests on Demapril-SP in order to allow these highly esteemed claims to be made about the product.

"Sometimes people with sensitive skin are nervous about trying a new skin care product because they fear allergic reactions," says Veronica Reina, general manager of Rauscher | Bekke. "Even those types of consumers can now feel very comfortable using Dermapril-SP."

Dermapril-SP with Matrixyl 3000™ offers revolutionary skincare technology that diminishes the appearance of fine lines, wrinkles and sagging to give skin a radiant and youthful look.

The first study monitored 50 human volunteers who applied Dermapril twice a day for eight weeks and then were checked for signs of adverse reactions. None of the subjects experienced any. That clears the way for Dermapril to be labeled 'Hypoallergenic'.

The second skin test watched 25 individuals self-described as having "highly sensitive" or "prone to negative reaction" skin. They were asked to apply Dermapril-SP to their skin twice a day for eight weeks. Not one person had any adverse reaction, allowing Rauscher | Bekke to label the wrinkle cream as 'Safe for Sensitive Skin.'

"When we submitted Dermapril-SP for testing we were cautiously optimistic about the outcome because we so rarely registered customer complaints about any sort of adverse reactions," says Reina. "But having a disciplined study like this makes us feel even better about the safety of our product."

Rauscher | Bekke is eager to indicate these new safety claims on the product packaging and marketing collateral.

For more information about Demapril, please visit Dermapril-SP by Rauscher | Bekke

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1Mb3ZlLVNxdWEtU3VtbS1Qcm9mLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Veronica Reina
Rauscher | Bekke LLC
(888) 727-4445
Email us Here
ATTACHED FILES


ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.
 
Close Move